Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
Since the first description of the association between chronic kidney disease and heart
disease, many epidemiological studies have confirmed and extended this finding. As …
disease, many epidemiological studies have confirmed and extended this finding. As …
Anemia and iron deficiency in heart failure: current concepts and emerging therapies
IS Anand, P Gupta - Circulation, 2018 - Am Heart Assoc
Anemia and iron deficiency are important and common comorbidities that often coexist in
patients with heart failure. Both conditions, together or independently, are associated with …
patients with heart failure. Both conditions, together or independently, are associated with …
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on …
2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American
College of Cardiology Foundation/American Heart Association Task Force on Practice …
College of Cardiology Foundation/American Heart Association Task Force on Practice …
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the …
Authors/Task Force Members, CW Hamm… - European heart …, 2011 - academic.oup.com
ESC Guidelines 3002 recommendations. To implement the guidelines, condensed pocket
guidelines versions, summary slides, booklets with essential messages, and an electronic …
guidelines versions, summary slides, booklets with essential messages, and an electronic …
[HTML][HTML] Daprodustat for the treatment of anemia in patients undergoing dialysis
Background Among patients with chronic kidney disease (CKD), the use of recombinant
human erythropoietin and its derivatives for the treatment of anemia has been linked to a …
human erythropoietin and its derivatives for the treatment of anemia has been linked to a …
Chronic kidney disease
Chronic kidney disease is a general term for heterogeneous disorders affecting kidney
structure and function. The 2002 guidelines for definition and classification of this disease …
structure and function. The 2002 guidelines for definition and classification of this disease …
Anemia in chronic kidney disease: from pathophysiology and current treatments, to future agents
Anemia is a common complication in chronic kidney disease (CKD), and is associated with a
reduced quality of life, and an increased morbidity and mortality. The mechanisms involved …
reduced quality of life, and an increased morbidity and mortality. The mechanisms involved …
[HTML][HTML] Roxadustat for anemia in patients with kidney disease not receiving dialysis
N Chen, C Hao, X Peng, H Lin, A Yin… - … England Journal of …, 2019 - Mass Medical Soc
Abstract Background Roxadustat (FG-4592) is an oral inhibitor of hypoxia-inducible factor
(HIF) prolyl hydroxylase that stimulates erythropoiesis and regulates iron metabolism. In …
(HIF) prolyl hydroxylase that stimulates erythropoiesis and regulates iron metabolism. In …
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease
Background Anemia is associated with an increased risk of cardiovascular and renal events
among patients with type 2 diabetes and chronic kidney disease. Although darbepoetin alfa …
among patients with type 2 diabetes and chronic kidney disease. Although darbepoetin alfa …
Mechanisms of anemia in CKD
JL Babitt, HY Lin - Journal of the American Society of Nephrology, 2012 - journals.lww.com
Anemia is a common feature of CKD associated with poor outcomes. The current
management of patients with anemia in CKD is controversial, with recent clinical trials …
management of patients with anemia in CKD is controversial, with recent clinical trials …